Sign in Subscribe
Cancer

Breakthrough in Cancer Treatment: American Oncology Institute Achieves Success with Hyperthermic Intraperitoneal Chemotherapy

Strategic Insights

— 1 min read

The American Oncology Institute (AOI) at ASCOMS Jammu has made a significant stride in complex cancer treatment by successfully performing a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) procedure on a patient with advanced ovarian cancer. This achievement highlights AOI Jammu's growing capabilities in delivering high-end cancer care and offering sophisticated treatment options. HIPEC is an advanced therapeutic technique that involves the surgical removal of visible tumors from the abdominal cavity followed by the infusion of heated chemotherapy directly into the peritoneal cavity. The procedure has demonstrated promising outcomes for specific cancers that have spread within the abdomen.

Key Takeaways:

  • AOI Jammu successfully performed the first HIPEC procedure in the region, marking a significant breakthrough in cancer treatment.
  • The patient, a 45-year-old woman, was diagnosed with high-grade ovarian cancer and underwent a multidisciplinary treatment approach involving neoadjuvant chemotherapy and HIPEC.
  • The HIPEC procedure involved meticulous removal of tumors from multiple sites within the abdominal cavity and infusion of heated chemotherapy for 90 minutes.
  • The patient had a smooth post-operative recovery and was discharged within a week, highlighting the teams' attention to detail and institutional readiness.
  • Dr. Avinash Rajra, Consultant Surgical Oncologist, emphasized the importance of HIPEC in selected cases, allowing for potentially curative treatment.
  • Dileep Mangsuli, Chairman, CTSI South Asia, praised AOI's commitment to bringing advanced cancer treatments to every region they serve.
  • Dr. Neeraj Bishnoi, Regional Chief Operating Officer of AOI North Region, highlighted the team's readiness to manage complex oncological cases with outcomes comparable to leading national centers.

Statistics:

  • The patient's age: 45
  • Duration of heated chemotherapy: 90 minutes
  • Number of centers in India performing HIPEC procedures: Only a limited number
  • Studies demonstrating HIPEC's efficacy: Several studies have shown that HIPEC can significantly extend survival and improve quality of life in patients with peritoneal surface malignancies.

Sources:

  • "Early Times" article, link: [insert link]
  • HT Digital Content Services with permission from Early Times. Copyright  HT Media Ltd.

Read more